Literature DB >> 7104463

The assessment of fractional drug removal by extracorporeal dialysis.

C S Lee.   

Abstract

It is generally concurred that the effectiveness of extracorporeal dialysis is best evaluated by fractional drug removal, i.e. the proportion of body burden of drug removed during the period of dialysis treatment. Two equations reported in the literature and five equations proposed in this article are examined for their validity in the assessment of fractional drug removal. Potential limitations and applicable conditions of these equations are discussed and compared. Calculations of fractional drug removal are demonstrated using both simulated and experimental data of ethambutol. Depending on the available kinetic measurements during dialysis and post dialysis, one may apply each equation separately or in conjunction with others to the calculation of fractional drug removal.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7104463     DOI: 10.1002/bdd.2510030207

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  7 in total

1.  Predicative calculation of the efficiency of hemodialysis or hemoperfusion for the removal of drugs from the body.

Authors:  H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

2.  Deconvolution applied to the kinetics of extracorporal drug removal. Haemodialysis of cefsulodin.

Authors:  W R Gillespie; P Veng-Pedersen; T P Gibson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Removal of imipenem and cilastatin by hemodialysis in patients with end-stage renal failure.

Authors:  K Konishi; H Suzuki; T Saruta; M Hayashi; N Deguchi; H Tazaki; A Hisaka
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 4.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

5.  Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.

Authors:  K Konishi
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

6.  Didanosine pharmacokinetics in patients with normal and impaired renal function: influence of hemodialysis.

Authors:  E Singlas; A M Taburet; F Borsa Lebas; O Parent de Curzon; A Sobel; P Chauveau; B Viron; R al Khayat; J L Poignet; F Mignon
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

7.  Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.

Authors:  K Konishi; H Suzuki; T Saruta; N Deguchi; T Fugono
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.